Kwan-Young Jung

Title: Kwan-Young Jung: Innovator in Neurological Pain Treatment

Introduction

Kwan-Young Jung is a notable inventor based in Buk-gu, Gwangju, South Korea. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target specific receptors involved in pain and inflammation.

Latest Patents

Kwan-Young Jung holds a patent for a novel pyridine carboxylic acid based compound used as a P2X1 and P2X3 receptor antagonist. This patent describes a production method for the compound and a composition that includes it. The compound is recognized for its powerful antagonistic properties against P2X1 and P2X3 receptors, making it a potential drug for treating or preventing diseases associated with neurological pain and chronic inflammatory conditions.

Career Highlights

Kwan-Young Jung is affiliated with the Gwangju Institute of Science and Technology, where he conducts research and development in the field of medicinal chemistry. His work focuses on creating innovative solutions for complex health issues, particularly those related to pain management.

Collaborations

Some of his notable coworkers include Yong-Chul Kim and Joong Heui Cho, who collaborate with him on various research projects aimed at advancing the understanding and treatment of receptor-related diseases.

Conclusion

Kwan-Young Jung's contributions to the field of pharmacology, particularly through his patented compound, highlight his role as an innovator in the treatment of neurological pain and chronic inflammation. His work continues to pave the way for new therapeutic options in medicine.